Literature DB >> 31597523

Circular RNA HIPK3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging miR-149.

Huibin Lu1, Xinwei Han1, Jianzhuang Ren1, Kewei Ren1, Zongming Li1, Zhanguo Sun1.   

Abstract

Circular RNAs (circRNAs) are a class of endogenous noncoding RNAs that are demonstrated to be potent regulators in the development of various types of human cancers, including non-small cell lung cancer (NSCLC). In the present study, the level of circRNA-HIPK3 were measured by Taq-man based quantitative real-time PCR (qRT-PCR) analysis in both NSCLC patient specimens and cells, which showed that circRNA-HIPK3 was upregulated in both NSCLC tissues and cell lines. Cell counting kit-8 (CCK-8), migration and flow-cytometry assays indicated that circRNA-HIPK3 participated in the regulation of the proliferation, migration, invasion and apoptosis of NSCLC cells. MiR-193a expression was increased by circHIPK3 silencing. We then showed that miR-149 interacts with FOXM1 by binding to the 3'-untranslated region (UTR). Further, ectopic overexpression of miR-149 by transfecting miR-149 mimics significantly inhibited growth, migration and invasion of HSCLCs, which was found to be mediated through FOXM1. Moreover, miR-149 overexpression decreases the viability and proliferation of HSCLCs. Therefore, our data suggest that circHIPK3 regulates the function of NSCLCs through miR-149-mediated FOXM1 expression regulation, potentially providing a novel insight into the pathogenesis of NSCLC.

Entities:  

Keywords:  Non-small cell lung cancer; circular RNAs; miR-149; pathogenesis

Year:  2019        PMID: 31597523      PMCID: PMC7012091          DOI: 10.1080/15384047.2019.1669995

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

Review 1.  Emerging landscape of circular RNAs in lung cancer.

Authors:  Wei Hu; Zhuo-Yue Bi; Zhen-Long Chen; Cong Liu; Lin-Lin Li; Feng Zhang; Qun Zhou; Wei Zhu; Yang-Yi-Yan Song; Bo-Tao Zhan; Qian Zhang; Yong-Yi Bi; Cheng-Cao Sun; De-Jia Li
Journal:  Cancer Lett       Date:  2018-04-11       Impact factor: 8.679

Review 2.  Genetic alterations defining NSCLC subtypes and their therapeutic implications.

Authors:  Larissa A Pikor; Varune R Ramnarine; Stephen Lam; Wan L Lam
Journal:  Lung Cancer       Date:  2013-08-20       Impact factor: 5.705

3.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer.

Authors:  Peifei Li; Shengcan Chen; Huilin Chen; Xiaoyan Mo; Tianwen Li; Yongfu Shao; Bingxiu Xiao; Junming Guo
Journal:  Clin Chim Acta       Date:  2015-02-14       Impact factor: 3.786

4.  Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis.

Authors:  Xuemei Ma; Xiaodong Yang; Wenhua Bao; Shumin Li; Shanshan Liang; Yunhui Sun; Yunwei Zhao; Jing Wang; Chenxu Zhao
Journal:  Biochem Biophys Res Commun       Date:  2018-03-16       Impact factor: 3.575

5.  Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer.

Authors:  Hanqing Yu; Yu Chen; Ping Jiang
Journal:  Biochem Biophys Res Commun       Date:  2018-10-20       Impact factor: 3.575

6.  Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis.

Authors:  Yongsheng Li; Jiahang Hu; Lijuan Li; Shengyan Cai; Hengchun Zhang; Xianfeng Zhu; Guijie Guan; Xiangmei Dong
Journal:  Biochem Biophys Res Commun       Date:  2018-08-06       Impact factor: 3.575

7.  Correlation of circular RNA abundance with proliferation--exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues.

Authors:  Anna Bachmayr-Heyda; Agnes T Reiner; Katharina Auer; Nyamdelger Sukhbaatar; Stefanie Aust; Thomas Bachleitner-Hofmann; Ildiko Mesteri; Thomas W Grunt; Robert Zeillinger; Dietmar Pils
Journal:  Sci Rep       Date:  2015-01-27       Impact factor: 4.379

8.  Circular RNA Complement Factor H (CFH) Promotes Glioma Progression by Sponging miR-149 and Regulating AKT1.

Authors:  Aimiao Bian; Yanping Wang; Ji Liu; Xiaodong Wang; Dai Liu; Jian Jiang; Lianshu Ding; Xiaobo Hui
Journal:  Med Sci Monit       Date:  2018-08-16

9.  Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.

Authors:  Yinjie Su; Weiping Yang; Ning Jiang; Juanyi Shi; Luping Chen; Guangzheng Zhong; Junming Bi; Wei Dong; Qiong Wang; Chunhui Wang; Tianxin Lin
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

10.  CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.

Authors:  Kaixuan Zeng; Xiaoxiang Chen; Mu Xu; Xiangxiang Liu; Xiuxiu Hu; Tao Xu; Huiling Sun; Yuqin Pan; Bangshun He; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

View more
  22 in total

1.  iCDA-CMG: identifying circRNA-disease associations by federating multi-similarity fusion and collective matrix completion.

Authors:  Qiu Xiao; Jiancheng Zhong; Xiwei Tang; Jiawei Luo
Journal:  Mol Genet Genomics       Date:  2020-11-06       Impact factor: 3.291

Review 2.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

3.  Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness.

Authors:  Mingming Jin; Xiyu Liu; Yue Wu; Yuqing Lou; Xue Li; Gang Huang
Journal:  Cancer Cell Int       Date:  2022-06-20       Impact factor: 6.429

Review 4.  CircHIPK3: a promising cancer-related circular RNA.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

5.  Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.

Authors:  Haitao Wei; Li Li; Haifeng Zhang; Feng Xu; Longqi Chen; Guowei Che; Yun Wang
Journal:  Cell Cycle       Date:  2021-01-08       Impact factor: 4.534

6.  The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells.

Authors:  Lvxia Dai; Xiaoping Yu; Sizhou Huang; Yanjuan Peng; Jianmin Liu; Tian Chen; Xin Wang; Qiaofeng Liu; Yanfeng Zhu; Dengbang Chen; Xiaohua Li; Yu Ou; Yi Zou; Qu Pan; Kang Cao
Journal:  Cancer Biol Ther       Date:  2020-12-30       Impact factor: 4.742

Review 7.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

Review 8.  Insights Into circRNAs: Functional Roles in Lung Cancer Management and the Potential Mechanisms.

Authors:  Bing Feng; Hao Zhou; Ting Wang; Xinrong Lin; Yongting Lai; Xiaoyuan Chu; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 9.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Circular RNA circHIPK3 promotes breast cancer progression via sponging MiR-326.

Authors:  Na Luo; Shiqin Liu; Xin Li; Yu Hu; Kejing Zhang
Journal:  Cell Cycle       Date:  2021-06-21       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.